Post-Cycle Hypogonadism After Anabolic Steroid Use: Treat Now or Wait
A single patient, ten weeks off a self-administered anabolic steroid cycle, with libido and energy that haven't recovered on their own. The disagreement is whether his numbers justify pharmacologic intervention or whether time, which resolves most cases, deserves more patience than his own competition calendar allows.
Trevor M., a 27-year-old warehouse shift supervisor and competitive amateur powerlifter, finished a twelve-week cycle of testosterone enanthate and trenbolone acetate ten weeks ago — his third cycle in four years, the first that hasn’t bounced back on schedule. He expected the flatness and low libido that follow every cycle’s end; what he didn’t expect was for it to still be here at ten weeks, long past when the first two recoveries had already turned a corner. His testosterone came back at 92 ng/dL, and his LH and FSH were both below assay detection — not just low-normal the way a milder suppression looks, but flat, the signature of an axis that supraphysiologic exposure has driven all the way to the floor.
A near-undetectable gonadotropin pair means the pituitary itself has essentially nothing left to withhold — there is no partial signal for an oral agent to amplify the way there would be in a milder case, which is part of why hCG, acting directly on the Leydig cells rather than waiting on the hypothalamus to respond, has intuitive appeal here. But the evidence behind intervening at all is thin: Grant and colleagues’ 2023 survey of endocrinologists managing exactly this presentation found that about eighty-four percent advise waiting out the recovery without any pharmacologic treatment, and the case series behind hCG and clomiphene combination therapy sit at a further remove from him than they first appear — Wenker and colleagues’ retrospective series of 49 men, the most cited of them, recovered sperm in 47 of them at a mean of 4.6 months, but enrolled men azoospermic or severely oligospermic on prescribed exogenous testosterone, not men coming off a self-administered stack. Trevor’s own deadline is his next meet in six months, a timeline the natural-recovery literature can’t promise but hasn’t ruled out either. What complicates a clean read of his own risk is the trenbolone itself: unlike testosterone, it isn’t aromatized to estrogen in any meaningful way, which means the estrogen-driven negative feedback loop that clomiphene is built to interrupt may not be the dominant mechanism keeping his own axis suppressed — a real reason his particular recovery might behave differently from the testosterone-only cases most of this literature actually describes.
In clinic, ten weeks off cycle
Grant and colleagues surveyed endocrinologists on this exact scenario in 2023, and the large majority — about eighty-four percent — recommend waiting, no drug. The evidence for hCG or clomiphene here is entirely case series — no randomized trial has ever tested treated recovery against watching it happen, and most men do recover on their own within a year.
If he weren't chasing a specific competition date, I wouldn't be tempted to move off that default at all.
I'd weight his numbers more than the average case in that survey. Undetectable LH and FSH isn't a mild, self-limiting suppression — it's close to the floor, and ‘most men recover within a year’ is a statement about averages, not about him specifically, six months out from a meet he's trained toward. I'd start combination hCG plus clomiphene now rather than watch a full recovery window pass.
Calling the evidence 'case series only' is accurate, but it's not the same as calling it absent — Wenker recovered sperm in 47 of 49 men at a mean of 4.6 months, which is a real signal even uncontrolled.
I'd split the difference by mechanism rather than by evidence tier. hCG stimulates Leydig cells directly — it doesn't depend on his hypothalamus recovering first, which matters when his own signal is already at zero. Clomiphene works by lifting hypothalamic output, and there may not be much left there to lift yet at ten weeks.
Start hCG alone, recheck testosterone and gonadotropins at eight weeks, and add clomiphene only if the response is incomplete. That gives him real intervention aimed at the part of the axis that's actually still responsive, without paying for two drugs' side-effect burden before we know one is needed.
Agreed: start hCG monotherapy today, with testosterone, LH, and FSH rechecked at eight weeks; clomiphene added only if that recheck shows incomplete recovery. The competitive deadline shaped the decision to intervene at all, but not the choice to start both drugs at once.
Not raised as settled: whether Trevor intends to cycle again after this competition. The sports medicine physician wanted that conversation on today’s agenda; the andrologist felt it belonged to a different visit, once the immediate hypogonadism is addressed rather than folded into the same appointment.